Leukemia inhibitory factor reduces body fat mass in ovariectomized mice
Author(s) -
JohnOlov Jansson,
Sofia MovérareSkrtic,
Anna Berndtsson,
Ingrid Wernstedt Asterholm,
Hans Carlsten,
Claes Ohlsson
Publication year - 2006
Publication title -
european journal of endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 148
eISSN - 1479-683X
pISSN - 0804-4643
DOI - 10.1530/eje.1.02082
Subject(s) - ovariectomized rat , leukemia inhibitory factor , medicine , endocrinology , glycoprotein 130 , leptin , estrogen , cytokine , adipose tissue , chemistry , estrous cycle , bone mineral , obesity , interleukin 6 , osteoporosis
Ovariectomized (OVX) mice are known to gain body fat while exposure to estrogens decreases fat mass. We have previously shown that estrogen replacement therapy enhances the expression of receptors for the cytokine, leukemia inhibitory factor (LIF). LIF and other cytokines acting via the gp130 signal transducing receptor have been reported to decrease obesity. In the present study, we investigated whether LIF treatment can reduce obesity in OVX mice.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom